.png)
Cytodrox Capsule (Hydroxyurea)
$25.00
Cytodrox Capsule (Hydroxyurea) contain the active ingredient Hydroxyurea, which is used to treat certain cancers and blood disorders. This medication works by slowing or stopping the growth of cancer cells and abnormal blood cells in the body. Cytodrox capsules are intended for oral use only and should be taken as directed by a healthcare professional. Patients should be regularly monitored while taking this medication to assess for any potential side effects and to ensure its effectiveness. This medication may also be prescribed for other purposes as directed by a healthcare provider.
Quantity
Uses of Cytodrox Capsule
- Treatment of Head and neck cancer
- Treatment of Blood cancer (Chronic myeloid leukaemia)
- Treatment of Sickle cell disease
Benefits of Cytodrox Capsule
In Treatment of Head and neck cancer
In patients with head and neck cancers, Cytodrox Capsule is often used alongside radiation therapy to enhance its effectiveness. It sensitizes cancer cells to radiation, improving treatment outcomes and helping to shrink tumors more effectively. This combined approach helps reduce pain, difficulty swallowing, and other cancer-related symptoms, thereby improving speech, eating, and daily comfort during therapy.
Side effects of Cytodrox Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Cytodrox
- Hair loss
- Bone marrow depression
- Low blood platelets
- Skin rash
- Mucositis
- Decreased appetite
- Cholestasis
- Hepatitis (viral infection of liver)
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Constipation
- Stomatitis (Inflammation of the mouth)
How to use Cytodrox Capsule
Take this medicine in the dose and duration as advised by your doctor. Cytodrox Capsule may be taken with or without food.
How Cytodrox Capsule works
In cancer, hydroxyurea inhibits the enzyme ribonucleotide reductase, which plays a critical role in the synthesis of DNA by converting ribonucleotides into deoxyribonucleotides. This inhibition disrupts DNA synthesis, particularly in rapidly dividing cancer cells, resulting in cell cycle arrest and reduced tumor proliferation. In sickle cell disease, hydroxyurea increases the production of fetal hemoglobin (HbF) in red blood cells. Higher levels of HbF reduce the formation of sickled cells, improve red blood cell flexibility, enhance blood flow, and decrease the frequency of painful vaso-occlusive episodes and related complications.